DNLI · Denali Therapeutics Inc.
$24.40
-0.42 (-1.69%)
At close · Aug 14
Market Cap
$3.90B
Shares
159.85M
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2025
| Executive | Role | Total |
|---|---|---|
| Ryan J. Watts | President and Chief Executive Officer | $4,751,515 |
| Alexander O. Schuth | Chief Operating and Financial Officer and Secretary | $4,258,045 |
| Carole Ho | Chief Medical Officer and Head of Development (until November 14, 2025) | $3,828,870 |
Fiscal 2024
| Executive | Role | Total |
|---|---|---|
| Ryan J. Watts | President and Chief Executive Officer | $6,557,662 |
| Alexander O. Schuth | Chief Operating and Financial Officer and Secretary | $4,022,759 |
| Carole Ho | Chief Medical Officer | $4,022,759 |
Fiscal 2023
| Executive | Role | Total |
|---|---|---|
| Ryan J. Watts | President and Chief Executive Officer | $7,879,267 |
| Carole Ho | Chief Medical Officer | $4,169,183 |
| Alexander O. Schuth | Chief Operating and Financial Officer and Secretary | $4,169,183 |
Fiscal 2022
| Executive | Role | Total |
|---|---|---|
| Ryan J. Watts | President and Chief Executive Officer | $9,284,688 |
| Alexander O. Schuth | Chief Operating and Financial Officer and Secretary | $5,692,052 |
| Carole Ho | Chief Medical Officer | $5,692,052 |
| Steve E. Krognes | Chief Financial Officer and Treasurer (until May 1, 2022) | $4,286,877 |
Fiscal 2021
| Executive | Role | Total |
|---|---|---|
| Ryan J. Watts | President and Chief Executive Officer | $12,673,479 |
| Steve E. Krognes | Chief Financial Officer and Treasurer (until May 1, 2022) | $6,587,660 |
| Carole Ho | Chief Medical Officer | $6,543,606 |
| Alexander O. Schuth | Chief Operating and Financial Officer and Secretary | $6,530,026 |
Fiscal 2020
| Executive | Role | Total |
|---|---|---|
| Ryan J. Watts | President and Chief Executive Officer | $9,302,445 |
| Carole Ho | Chief Medical Officer | $4,325,347 |
| Steve E. Krognes | Chief Financial Officer and Treasurer (until May 1, 2022) | $4,266,044 |
| Alexander O. Schuth | Chief Operating and Financial Officer and Secretary | $4,203,402 |
Fiscal 2019
| Executive | Role | Total |
|---|---|---|
| Ryan J. Watts | President and Chief Executive Officer | $4,978,607 |
| Steve E. Krognes | Chief Financial Officer and Treasurer | $2,530,685 |
| Carole Ho | Chief Medical Officer | $2,489,571 |
| Alexander O. Schuth | Chief Operating Officer and Secretary | $2,476,628 |
Fiscal 2018
| Executive | Role | Total |
|---|---|---|
| Ryan J. Watts | President and Chief Executive Officer | $5,983,923 |
| Steve E. Krognes | Chief Financial Officer and Treasurer | $4,001,231 |
| Carole Ho | Chief Medical Officer | $3,935,469 |
| Alexander O. Schuth | Chief Operating Officer and Secretary | $3,901,789 |
Fiscal 2017
| Executive | Role | Total |
|---|---|---|
| Carole Ho | Chief Medical Officer | $1,367,997 |
| Ryan J. Watts | President and Chief Executive Officer | $1,366,863 |
| Steve E. Krognes | Chief Financial Officer and Treasurer | $1,166,560 |
| Alexander O. Schuth | Chief Operating Officer and Secretary | $1,076,937 |
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Steve Krognes | Board of Directors | Appointed | 2022-03-16 |
| Alexander Schuth | Chief Financial Officer | Appointed | 2022-03-16 |
| Erik Harris | Board of Directors | Appointed | 2022-02-07 |
Key facts
CIK
1714899
CUSIP
24823R105
13F (30d)
277 filings
272 filers
Visit website
Investor relations